52

DAFTAR PUSTAKA

1. Departemen Kesehatan RI. Statistik Kasus HIV/AIDS di Indonesia sampai

dengan 30 Juni 2014. Jakarta : Direktorat Jendral Pengendalian Penyakit dan
Penyehatan Lingkungan. 2014.
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global Report,
UNAIDS Report on the Global AIDS Epidemic 2013. Geneva : WHO
Library Cataloguing-in-Publication Data. 2013.
3. Dinas Kesehatan Provinsi Sumatera Utara. Gambaran Kasus HIV dan AIDS
di Sumatera Utara Sampai Dengan Januari 2015. Available from URL :
http://download.portalgaruda.org/article.php?article=438132&val=4108&title
=FAKTOR-
FAKTOR%20YANG%20BERHUBUNGAN%20DENGAN%20KEPATUH
AN%20PENDERITA%20HIV/AIDS%20MENGONSUMSI%20OBAT%20
ANTIRETROVIRAL%20(ARV)%20DI%20KLINIK%20VOLUNTARY%2
0COUNSELING%20AND%20TESTING%20(VCT)%20RSUP%20H.%20A
DAM%20MALIK%20MEDAN%20TAHUN%202014 Accessed March 19
2017.
4. Gonzales-Duarte A, Cikurel K, Simpson DM. Selected Neurologic
Complication of HIV and Antiretroviral Therapy. The PRN Notebook 2006;
vol 11 number 2 : 24 – 29.
5. Bartlett J, Gallant J. Medical Management of HIV. Maryland : John Hopkins
Medicine Health Publishing Business Group; 2007. P. 450-52
6. Nath. Changing Pattern and Pathophysiology of Cognitive Disfunction With
HIV Infection in the Era of Antiretroviral. J Neuro Virol. 2011; 17 : 1 – 2
7. Moore D, Letendre S, Morris S, Umlauf A, Deutsch R, Smith D, et al.
Neurocognitive Functioning in Acute or Early HIV Infection. J Neuro Virol.
2011; 17 : 50 – 7
 53

8. Robertson K, Liner J, Heaton S. Neuropsychological Assessment of HIV-

Infected Populations in International Settings. Neuropsychol Rev. 2009; 19 :
232 – 249
9. Ciccarelli N, Fabbiani M, Giambenedetto SD, Fanti I, Colafigli M, Bracciale
L, et al. Prevalence and Correlates of Minor Neurocognitive Disorder in
Asymptomatic HV-infected Outpatients. Rome : Institute of Infectious
Clinical Disease Catholic University of Sacred Heart; 2010. Poster number
417
10. Tozzi V, Balestra P, Lorenzini P, Bellagamba R, Galgani S, Corpolongo A, et
al. Prevalence and risk factors for human immunodeficiency virus–associated
neurocognitive impairment, 1996 to 2002: Results from an urban
observational cohort. Journal of NeuroVirology. 2005; 11 : 265 – 273
11. Ances BM, Ellis RJ. Dementia and Neurocognitive Disorders Due to HIV-1
Infection. Semin Neurol. 2007; 27 : 86 – 92
12. Carey CL, Woods SP, Rippeth JD, Heaton RK, Grant I, The HIV
Neurobehavioral Research Center (HNRC) Group. Prospective Memory in
HIV-1 Infection. J Clin Exp Neuropsychol. 2006 ; 28(4): 536–548
13. Woods SP, Iudicello JE, Moran LM, Carey CL, Dawson MS, Grant I, et al.
HIV-associated Prospective Memory Impairment Increases Risk of
Dependence in Everyday Functioning. Neuropsychology. 2008 ; 22(1): 110–
117
14. Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and
cognitive impairment in the cART era: a review. AIDS. 2011; 25 : 561–575
15. Rosenberg PB, Johnston D, Lyketsos CG. A Clinical Approach to Mild
Cognitive Impairment. Am J Psychiatry 2006; 163 (11) : 1884-9
16. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V,
Collin I, et al. The Montreal Cognitive Assessment, MoCA: A Brief
Screening Tool For Mild Cognitive Impairment. J Am Geriatr Soc. 2005; 53:
695–699
 54

17. Husein N, Lumempouw S, Ramli Y, Herqutanto. Uji Validitas dan

Reliabilitas Montreal Cognitive Assessment versi Indonesia (MoCA-Ina)
Untuk Skrining Gangguan Fungsi Kognitif. Neurona. 2010; 27 (4) : 15 – 22
18. Strub RL, Black FW. The Mental Status Examination In Neurology.4th
ed.Philadelphia:F.A. Davis Company; 2000
19. Perhimpunan Dokter Spesialis Saraf Indonesia. Modul Neurobehaviour.
Kolegium Neurologi Indonesia; 2008
20. Waxman SG. The Limbic System. Clinical Neuroanatomy. New York: The
MacGraw – Hill Companies; 2007
21. Markam S. Pengantar Neuropsikologi. Jakarta: Balai Penerbit FKUI; 2003
22. Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state
examination in the detection of dementia and mild cognitive impairment.
Journal of Psychiatric research. 2009; 43 (4) : 411-31
23. Woods SP, Moran LM, Carey CL, Dawson MS, Iudicello JE, Gibson S, et al.
Prospective Memory in HIV Infection: Is “Remembering to Remember” a
Unique Predictor of Self-reported Medication Management?. Arch Clin
Neuropsychol. 2008; 23 (3) : 257–270
24. Knight RG. Prospective memory. In AI Tröster (Ed.), Memory in
neurodegenerative disease: Biological, clinical, and cognitive perspectives.
New York : Cambridge University Press; 1998. Pp. 172 – 183
25. Einstein GO, McDaniel MA. Normal aging and prospective memory. Journal
of Experimental Psychology: Learning, Memory, and Cognition. 1990; 16 :
717–726
26. Einstein GO, McDaniel MA, Richardson SL, Guynn MJ. Aging and
prospective memory: Examining the influences of self-initiated retrieval.
Journal of Experimental Psychology: Learning, Memory, and Cognition.
1995; 21 : 996–1007
27. Henry JD, MacLeod M, Phillips L, Crawford JR. A meta-analytic review of
prospective memory and aging. Psychology and Aging. 2004; 19 : 27–39
 55

28. Kliegel M, Jäger T, Altgassen M, Shum D. Clinical neuropsychology of

prospective memory. In: Kliegel M, McDaniel MA, Einstein GO editors.
Prospective memory: Cognitive, neuroscience, developmental, and applied
perspectives. Mahwah, NJ : Lawrence Erlbaum Associates; 2008. p. 283-288
29. Gupta S, Woods SP, Weber E, Dawson MS, Grant I, The HIV
Neurobehavioral Research Center (HNRC) Group. Is prospective memory a
dissociable cognitive function in HIV infection?. Journal of Clinical and
Experimental Neuropsychology. 2010; 32 (8) : 898-908
30. Basso D, Ferrari M, Palladino P. Prospective memory and working memory:
asymmetrical effects during frontal lobe TMS stimulation. Neuropsychologia.
2010; 48 : 3282–3290
31. Burgess PW, Quayle A, Frith CD. Brain regions involved in prospective
memory as determined by positron emission tomography. Neuropsychologia.
2001; 39 : 545–555
32. Gordon BA, Shelton JT, Bugg JM, McDaniel MA, Head D. Structural
correlates of prospective memory. Neuropsychologia. 2011; 49 : 3795–3800
33. Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, et al.
Cliniconeuropathologic correlates of human immunodeficiency virus in the
era of antiretroviral therapy. Journal of Neurovirology. 2009; 15 : 360–370
34. Doyle KL, Loft S, Morgan EE, Weber E, Cushman C, Johnston E, et al.
Prospective memory in HIV-associated neurocognitive disorders (HAND):
The neuropsychological dynamics of time monitoring. Journal of Clinical and
Experimental Neuropsychology. 2013a; 35 : 359–372
35. Woods SP, Dawson MS, Weber E, Gibson S, Grant I, Atkinson JH, et al.
Timing is everything: Antiretroviral non- adherence is associated with
impairment in time- based prospective memory. Journal of the International
Neuropsychological Society. 2009; 15 : 42–52
36. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, et al.
HIV-associated neurocognitive disorders persist in the era of potent
antiretroviral therapy: CHARTER Study. Neurology. 2010; 75 : 2087–2096
 56

37. Morgan EE, Weber E, Rooney AS, Grant I, Woods SP, The HNRP Group.
Longer ongoing task delay intervals exacerbate prospective memory deficits
in HIV-associated neurocognitive disorders (HAND). Journal of Clinical and
Experimental Neuropsychology. 2012; 34 : 416–427
38. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, et al.
The impact of HIV-associated neuropsychological impairment on everyday
functioning. Journal of the International Neuropsychological Society. 2004;
10 : 317–331
39. Raskin SA. Memory for Intentions Screening Test: Psychometric Properties
and Clinical Evidence. Brain Impairment. 2009; 10 (1)
40. Kliegel M, Martin M, McDaniel M, & Einstein G. Complex prospective
memory and executive control of working memory: A process model.
Psychologische Beitrage. 2002; 44 : 303–318
41. Wilson BA, Emslie H, Foley J, Shiel A, Watson P, Hawkins K, et al. The
Cambridge Prospective Memory Test. London: Harcourt Assessment; 2005
42. Levinson W. Review of Medical Microbiology and Immunology 12th ed. New
York : Mc Graw Hill; 2012
43. Weiss, RA. HIV and AIDS : Looking Ahead. Nature Medicine. 2003; 9 (7) :
887 – 891
44. Mamidi A, DeSimone J, Pomerantz R. Central Nervous System Infections in
Individuals with HIV-1 Infection. J NeuroVirol. 2002; 8 : 158 – 67
45. Karn J. HIV volume 1 : Virology and Immunology. USA : Oxford University
Press; 2007
46. Levy J. HIV and Pathogenesis of AIDS 3rd ed. Washington DC : American
Society for Microbiology Press; 2007
47. Skiest D. Focal Neurological Disease in Patient With Acquired
Immunodeficiency Syndrome. Clin Infect Dis. 2002; 34 : 103 – 15
48. Boisse L, Gill J, Power C. HIV Infection of The Central Nervous System :
Clinical Features and Neuropathogenesis. Neurol Clin. 2008; 799 – 819
49. Kolegium Neurologi Indonesia. Modul Neuroinfeksi. Jakarta : PERDOSSI;
2008. p. 75 – 79
 57

50. Nasronudin. HIV & AIDS Pendekatan Biologi Molekuler, Klinis dan Sosial.
Surabaya : Airlangga University Press; 2007
51. Valcour V, Yee P, Williams A, Shiramizu B, Watters M, Selnes O, et al.
Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current
cognitive and neurological status in human immunodeficiency virus type 1
infection – The Hawaii aging with HIV cohort. J NeuroVirol. 2006; 12 : 387
– 91
52. Ghafouri M, Amini S, Khalili K, Sawaya BE. HIV-1 associated dementia:
symptoms and causes. Retrovirology. 2006; 3 : 28
53. Sugianto P. 2008. Diagnosis dan tata laksana infeksi oportunistik HIV pada
sistem saraf pusat. Dalam: Machhfoed, H., Susilo, H. and Suharjanti, S., ed.
2010. Makalah lengkap pendidikan kedokteran berkelanjutan Ilmu Penyakit
Saraf. Surabaya: Airlangga University Press, pp.351-364
54. Kaul M, Lipton SA. Mechanisms of Neuronal Injury and Death in HIV-1
Associated Dementia. Current HIV Research. 2006; 4 : 307 – 318
55. Radford KA, Lah S, Say MJ, Miller LA. Validation of a New Measure of
Prospective Memory: The Royal Prince Alfred Prospective Memory Test.
The Clinical Neuropsychologist. 2011; 25 (1) : 127–140
56. Stuart dan Sundeen. 1998. Buku Saku Keperawatan Jiwa Edisi 3 alih bahasa
Achir Yani. S. Jakarta : EGC